144 related articles for article (PubMed ID: 34031448)
1. Agreement between laboratory-based and non-laboratory-based Framingham risk score in Southern Iran.
Rezaei F; Seif M; Gandomkar A; Fattahi MR; Hasanzadeh J
Sci Rep; 2021 May; 11(1):10767. PubMed ID: 34031448
[TBL] [Abstract][Full Text] [Related]
2. Laboratory-based versus non-laboratory-based World Health Organization risk equations for assessment of cardiovascular disease risk.
Dehghan A; Rayatinejad A; Khezri R; Aune D; Rezaei F
BMC Med Res Methodol; 2023 Jun; 23(1):141. PubMed ID: 37322418
[TBL] [Abstract][Full Text] [Related]
3. A comparison of laboratory-based and office-based Framingham risk scores to predict 10-year risk of cardiovascular diseases: a population-based study.
Dehghan A; Ahmadnia Motlagh S; Khezri R; Rezaei F; Aune D
J Transl Med; 2023 Oct; 21(1):687. PubMed ID: 37789412
[TBL] [Abstract][Full Text] [Related]
4. A comparative assessment between Globorisk and WHO cardiovascular disease risk scores: a population-based study.
Dehghan A; Rezaei F; Aune D
Sci Rep; 2023 Aug; 13(1):14229. PubMed ID: 37648706
[TBL] [Abstract][Full Text] [Related]
5. Comparison of laboratory-based and non-laboratory-based WHO cardiovascular disease risk charts: a population-based study.
Rezaei F; Seif M; Gandomkar A; Fattahi MR; Malekzadeh F; Sepanlou SG; Hasanzadeh J
J Transl Med; 2022 Mar; 20(1):133. PubMed ID: 35296342
[TBL] [Abstract][Full Text] [Related]
6. Laboratory-based and office-based Globorisk scores to predict 10-year risk of cardiovascular diseases among Iranians: results from the Fasa PERSIAN cohort.
Jahangiry L; Dehghan A; Farjam M; Aune D; Rezaei F
BMC Med Res Methodol; 2022 Nov; 22(1):305. PubMed ID: 36435774
[TBL] [Abstract][Full Text] [Related]
7. Framingham ten-year general cardiovascular disease risk: agreement between BMI-based and cholesterol-based estimates in a South Asian convenience sample.
Jones CA; Ross L; Surani N; Dharamshi N; Karmali K
PLoS One; 2015; 10(3):e0119183. PubMed ID: 25781949
[TBL] [Abstract][Full Text] [Related]
8. Agreement between ten-years cardiovascular disease risk assessment tools: An application to Iranian population in Shahedieh Cohort Study.
Momayyezi M; Sefidkar R; Fallahzadeh H
Heliyon; 2023 Oct; 9(10):e20396. PubMed ID: 37810856
[TBL] [Abstract][Full Text] [Related]
9. Association between health literacy and Framingham risk score.
Rahimi T; Hashemi SS; Rezaei F; Aune D
Sci Rep; 2024 Jun; 14(1):12837. PubMed ID: 38834663
[TBL] [Abstract][Full Text] [Related]
10. Agreement between the laboratory-based and non-laboratory-based WHO cardiovascular risk charts: a cross-sectional analysis of a national health survey in Peru.
Guzman-Vilca WC; Quispe-Villegas GA; Váscones Román FF; Bernabe-Ortiz A; Carrillo-Larco RM
BMJ Open; 2022 Nov; 12(11):e063289. PubMed ID: 36344007
[TBL] [Abstract][Full Text] [Related]
11. Agreement between the SCORE and D'Agostino Scales for the classification of high cardiovascular risk in sedentary spanish patients.
Gómez-Marcos MA; Grandes G; Iglesias-Valiente JA; Sánchez A; Montoya I; García-Ortiz L;
Int J Environ Res Public Health; 2009 Nov; 6(11):2800-11. PubMed ID: 20049225
[TBL] [Abstract][Full Text] [Related]
12. A comparative assessment of non-laboratory-based versus commonly used laboratory-based cardiovascular disease risk scores in the NHANES III population.
Pandya A; Weinstein MC; Gaziano TA
PLoS One; 2011; 6(5):e20416. PubMed ID: 21655241
[TBL] [Abstract][Full Text] [Related]
13. Validity of noninvasive composite scores to assess cardiovascular risk in 10-year-old children.
Lerum Ø; Aadland E; Andersen LB; Anderssen SA; Resaland GK
Scand J Med Sci Sports; 2017 Aug; 27(8):865-872. PubMed ID: 28090680
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Nonblood-Based and Blood-Based Total CV Risk Scores in Global Populations.
Gaziano TA; Abrahams-Gessel S; Alam S; Alam D; Ali M; Bloomfield G; Carrillo-Larco RM; Dorairaj P; Gutierrez L; Irazola V; Levitt NS; Miranda JJ; Bernabe-Ortiz A; Pandya A; Rubinstein A; Steyn K; Xavier D; Yan LL
Glob Heart; 2016 Mar; 11(1):37-46.e2. PubMed ID: 27102021
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Laboratory and Non-Laboratory-Based 2019 World Health Organization Cardiovascular Risk Charts in the Bhutanese Population.
Chhezom K; Gurung MS; Wangdi K
Asia Pac J Public Health; 2024 Jan; 36(1):29-35. PubMed ID: 38116599
[TBL] [Abstract][Full Text] [Related]
16. Comparison between the Framingham and prospective cardiovascular of Münster scores for risk assessment of coronary heart disease in human immunodeficiency virus-positive patients in Pernambuco, Brazil.
Barros ZM; de Alencar Ximenes RA; Miranda-Filho DB; de Albuquerque Mde F; Melo HR; Carvalho EH; Gelenske T; Diniz G; Bandeira F
Metab Syndr Relat Disord; 2010 Dec; 8(6):489-97. PubMed ID: 20973693
[TBL] [Abstract][Full Text] [Related]
17. Prediction of cardiovascular risk in cancer patients of South India using WHO/ISH risk prediction charts and Framingham score - A prospective study.
Rajanandh MG; Suresh S; Manobala K; Nandhakumar R; Jaswanthi G; Neha S
J Oncol Pharm Pract; 2018 Jul; 24(5):354-358. PubMed ID: 28454502
[TBL] [Abstract][Full Text] [Related]
18. [Cardiovascular risk profile in 40-year old men and 50-year old women in the Czech Republic: results of a cross-sectional survey].
Vrablík M; Chmelík Z; Lánská V
Vnitr Lek; 2014 Nov; 60(11):991-7. PubMed ID: 25600047
[TBL] [Abstract][Full Text] [Related]
19. Prediction of cardiovascular disease risk using framingham risk score among office workers, Iran, 2017.
Nakhaie MR; Koor BE; Salehi SO; Karimpour F
Saudi J Kidney Dis Transpl; 2018; 29(3):608-614. PubMed ID: 29970737
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and associated cardiovascular risk factors in Iran: the Isfahan Healthy Heart Programme.
Sadeghi M; Roohafza H; Shirani S; Poormoghadas M; Kelishadi R; Baghaii A; Sarraf-Zadegan N
Ann Acad Med Singap; 2007 Mar; 36(3):175-80. PubMed ID: 17450262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
